Skip to content

EBITDA margin at other companies

Eli Lilly logo
Eli LillyLLY
45.9%+14.4pp
Johnson & Johnson logo
Johnson & JohnsonJNJ
34.4%+2.7pp
Amgen logo
AmgenAMGN
41.5%+3.4pp
AbbVie logo
AbbVieABBV
37.3%
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
-956.8%+257pp
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-15,497.7%-17,225pp

Other financials

Income statement

See full
Revenue-
Operating income-$15.5M-8.0%
Net income-$14.8M-7.8%
EPS (diluted)-$0.13+51.9%

Balance sheet

See full
Cash & equivalents$90.4M+48.5%
Total debt$2.9M-9.5%
Total equity$95.8M+41.8%
Total assets$102.1M+32.3%

Cash flow

See full
Operating cash flow-$13.4M-11.6%
CapEx$63.0K
Free cash flow-$13.5M-12.1%

Valuation

See full
Market cap$564.45M+1,131%
Enterprise value$476.92M-4,119%
P/S564.5×+554×

Profitability

See full
Operating margin-5,266.4%-9,520pp
Net margin-4,987.4%-8,966pp
FCF margin-4,140.8%-7,144pp

Returns & leverage

See full
Return on equity-61%-8.0pp
Debt / equity0.0×
Current ratio22.1×+13.0×

Where this comes from

Calculated from Shattuck Labs, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Shattuck Labs, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Shattuck Labs, Inc.'s ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Shattuck Labs, Inc.'s EBITDA margin?
Shattuck Labs, Inc. (STTK) reported EBITDA margin of -4,902.1% in Q1 2026.
How has Shattuck Labs, Inc.'s EBITDA margin changed year-over-year?
Shattuck Labs, Inc.'s EBITDA margin decreased by 217.5% year-over-year, from -1,544.1% to -4,902.1%.
What is the long-term trend for Shattuck Labs, Inc.'s EBITDA margin?
Over 4 years (2020 to 2025), Shattuck Labs, Inc.'s EBITDA margin has grown at a 90.2% compound annual growth rate (CAGR), from -365.5% to -4,782%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.